Devyser acquires Swedish company Cybergene AB and strengthens its position in the aneuploidy market
Devyser Diagnostics AB (publ), a Swedish molecular diagnostics company, today announces that it has...
QF-PCR in pregnancy loss samples by Dr Helen White
Traditionally, karyotype analysis of pregnancy loss samples has been the gold standard method for evaluating the genetic cause of pregnancy loss. However, this approach is labour intensive, expensive, requires highly trained technical staff and is often unsuccessful due to the high tissue culture failure rate. Several alternative methodologies to karyotype analysis have been used to investigate genetic abnormalities in pregnancy loss. The QF-PCR method is one of them that is now used more widely for the analysis of pregnancy loss samples..
QF-PCR in pregnancy loss samples by Dr Helen White
Traditionally, karyotype analysis of pregnancy loss samples has been the gold standard method for evaluating the genetic cause of pregnancy loss. However, this approach is labour intensive, expensive, requires highly trained technical staff and is often unsuccessful due to the high tissue culture failure rate. Several alternative methodologies to karyotype analysis have been used to investigate genetic abnormalities in pregnancy loss. The QF-PCR method is one of them that is now used more widely for the analysis of pregnancy loss samples..
Devyser Diagnostics AB (publ), a Swedish molecular diagnostics company, today announces that it has...
Read More
Devyser today announced that it entered a strategic agreement with Illumina, a global leader in DNA...
Read More
Devyser is proud to announce that the company has been awarded a tender by Oslo University Hospital...
Read More
Devyser, a leading provider of advanced genetic testing solutions, has been awarded a new tender in...
Read More